244 results on '"Comont, Thibault"'
Search Results
2. Chronic Myelomonocytic Leukemia Patients With Lysozyme Nephropathy and Renal Infiltration Display Markers of Severe Disease
3. Prolonged response after TPO-RA discontinuation in primary ITP: results of a prospective multicenter study
4. Immune thrombocytopenia and pregnancy: an exposed/nonexposed cohort study
5. MAIT cells numbers and frequencies in patients with acute myeloid leukemia at diagnosis: association with cytogenetic profile and gene mutations
6. Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEX.
7. Immune thrombocytopenia newly diagnosed during pregnancy: Outcome for mothers and neonates and comparison with chronic immune thrombocytopenia during pregnancy.
8. Immune checkpoint inhibitor-related acquired amegakaryocytosis thrombocytopenia: a case report and literature review
9. Activated PI3 Kinase Delta Syndrome Revealed by Vasculitis and Disseminated Toxoplasmosis
10. A Complex Infectious, Inflammatory, and Autoimmune Phenotype Reveals 22q11.2 Deletion Syndrome in an Adult
11. Drug‐induced autoimmune hemolytic anemias related to immune checkpoint inhibitors, therapeutic management, and outcome.
12. Serious infections in patients with VEXAS syndrome: data from the French VEXAS registry
13. The CARMEN-France registry of adult patients with immune thrombocytopenia and autoimmune hemolytic anemia in France
14. Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study
15. Difficult‐to‐treat primary immune thrombocytopenia in adults: Prevalence and burden. Results from the CARMEN‐France registry.
16. Platelet count threshold for hemorrhage in patients with immune thrombocytopenia treated with antiplatelet agents
17. S162: LOSS OF HEMATOPOIETIC PROGENITORS HETEROGENEITY IS AN ADVERSE PROGNOSTIC FACTOR IN MYELODYSPLASTIC SYNDROMES
18. P1613: REAL-WORLD USE OF FOSTAMATINIB IN FRANCE. INTERIM RESULTS OF A NATIONAL REGISTRY.
19. Platelet transfusion refractoriness in patients with acute myeloid leukemia treated by intensive chemotherapy
20. Long-term follow-up of the STOPAGO study
21. A Clinicopathological Description of Kidney Features in VEXAS Syndrome
22. Risk of vaso-occlusive episodes in patients with sickle cell disease exposed to systemic corticosteroids: a comprehensive review
23. Multirefractory Primary Immune Thrombocytopenia in Adults: Prevalence and Burden. Results from the Carmen-France Registry
24. Platelet Count Threshold Associated with Bleeding in Adult Patients with Immune Thrombocytopenia Treated with Antiplatelet Drugs. Results from the Carmen-France Registry
25. Immune checkpoint inhibitor-related acral vasculitis
26. Characteristics and outcome of adults with severe autoimmune hemolytic anemia admitted to the intensive care unit: Results from a large French observational study
27. Sample CME manuscript submission: Response to the article by Pham et al entitled “Review BRAF inhibition and the spectrum of granulomatous reactions”
28. An appraisal of the frequency and severity of noninfectious manifestations in primary immunodeficiencies: A study of a national retrospective cohort of 1375 patients over 10 years
29. Splenectomy for Primary Immune Thrombocytopenia Revisited at the Era of Thrombopoietin Receptor Agonists: New Insights for an Old Treatment
30. Azacitidine (AZA) for Patients with Vexas and Myelodysplastic Syndrome (MDS): Data from the French Vexas Registry
31. A Phase II Study of the Efficacy and Tolerance of Azacytidine (AZA) in Steroid Dependent/Refractory Systemic Autoimmune and Inflammatory Disorders (SAID) Associated with MDS or CMML (GFM- AZA-SAID -trial)
32. Association between Megakaryocyte Abnormalities on Bone Marrow Smear and Response to Thrombopoietin Receptor Agonists in Adult Patients with Primary Immune Thrombocytopenia
33. Characteristics and Outcome of Adults with Severe Autoimmune Hemolytic Anemia Admitted in Intensive Care Unit: Results from a Large French Observational Study
34. Splenectomy for primary immune thrombocytopenia revisited in the era of thrombopoietin receptor agonists: New insights for an old treatment
35. From Immune Dysregulations to Therapeutic Perspectives in Myelodysplastic Syndromes: A Review
36. MAIT cells numbers and frequencies in patients with acute myeloid leukemia at diagnosis: association with cytogenetic profile and gene mutations
37. Daratumumab, an original approach for treating multi-refractory autoimmune cytopenia
38. Serious Infections in Patients with Vexas Syndrome: A Study from the French Vexas Group
39. Efficacy and Safety of Luspatercept +/- Erythropoiesis-Stimulating Agent (ESA) in Patients with Myelodysplastic Syndromes with Ring Sideroblasts (MDS-RS): A French Multicenter Prospective Real-Life Registry
40. Autoimmune Cytopenia Associated with Indolent B-Cell Clones: A Large Multicentric Cohort Study
41. Significance of antinuclear antibodies in primary immune thrombocytopenia: results of the CARMEN registry
42. Characteristic vacuolisation of granulocytic and erythroid precursors associated with VEXAS syndrome
43. Clinical spectrum, outcome and management of immune thrombocytopenia associated with myelodysplastic syndromes and chronic myelomonocytic leukemia
44. Improving the diagnostic efficiency of primary immunodeficiencies with targeted next-generation sequencing
45. Primary immune thrombocytopenia in very elderly patients: particularities in presentation and management: results from the prospective CARMEN‐France Registry.
46. Low dose IL-2 in patients with steroid-dependent dysimmune manifestations associated with myelodysplastic syndromes: a three-case report
47. Outcome of Immune Thrombocytopenia in Pregnancy: A French Nationwide Prospective Multicenter Observational Case-Control Study
48. Risk Factors of Neonatal Immune Thrombocytopenia in Pregnant Women Previously Diagnosed with ITP: Results from a French Nationwide Prospective Study
49. Nivolumab-induced eosinophilic fasciitis: a case report
50. Severe haemophagocytic lymphohistiocytosis triggered by a visceral leishmaniasis in a patient with a Rosai-Dorfman disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.